User contributions for ShiSheng
Jump to navigation
Jump to search
26 December 2013
- 21:2521:25, 26 December 2013 diff hist 0 File:Imipenem ilastatin 10.png ShiSheng uploaded a new version of "File:Imipenem ilastatin 10.png" current
- 21:2021:20, 26 December 2013 diff hist 0 N File:Imipenem ilastatin 9.png No edit summary current
- 21:1821:18, 26 December 2013 diff hist −1 Imipenem cilastatin adverse reactions →Pediatric Patients
- 21:1621:16, 26 December 2013 diff hist 0 File:Imipenem Cilastatin 5.jpg ShiSheng uploaded a new version of "File:Imipenem Cilastatin 5.jpg" current
- 21:1121:11, 26 December 2013 diff hist 0 N File:Imipenem ilastatin 7.png No edit summary current
- 21:0521:05, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 5.jpg No edit summary
- 21:0421:04, 26 December 2013 diff hist +20 Imipenem cilastatin adverse reactions →Pediatric Patients
- 21:0421:04, 26 December 2013 diff hist +99 Imipenem cilastatin adverse reactions →Pediatric Patients
- 21:0121:01, 26 December 2013 diff hist 0 Imipenem cilastatin microbiology →Quality Control
- 21:0121:01, 26 December 2013 diff hist 0 Imipenem cilastatin microbiology →Anaerobic Techniques
- 21:0021:00, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 4.jpg No edit summary current
- 20:5820:58, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 15.jpg No edit summary current
- 20:5820:58, 26 December 2013 diff hist +1 Imipenem cilastatin clinical pharmacology No edit summary
- 20:5420:54, 26 December 2013 diff hist +55 Imipenem cilastatin microbiology →Microbiology
- 20:3020:30, 26 December 2013 diff hist −1 Imipenem cilastatin indications and usage No edit summary
- 20:2920:29, 26 December 2013 diff hist +266 Imipenem cilastatin indications and usage →Indications And Usage
- 20:2720:27, 26 December 2013 diff hist 0 Imipenem cilastatin clinical pharmacology →Intravenous Administration
- 20:2720:27, 26 December 2013 diff hist +30 Imipenem cilastatin clinical pharmacology →Intravenous Administration
- 20:2320:23, 26 December 2013 diff hist −250 Cefaclor microbiology No edit summary
- 20:2220:22, 26 December 2013 diff hist +250 Cefaclor microbiology →AnAerobes, Gram-positive
- 20:2120:21, 26 December 2013 diff hist +60 Imipenem cilastatin description No edit summary
- 20:1920:19, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 14.jpg No edit summary current
- 20:1920:19, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 13.jpg No edit summary current
- 20:1920:19, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 12.jpg No edit summary current
- 20:1820:18, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 11.jpg No edit summary
- 20:1820:18, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 10.jpg No edit summary
- 20:1720:17, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 9.jpg No edit summary
- 20:1720:17, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 8.jpg No edit summary
- 20:1720:17, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 7.jpg No edit summary current
- 20:1620:16, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 6.jpg No edit summary current
- 20:1620:16, 26 December 2013 diff hist 0 File:Doripenem 5.jpg ShiSheng uploaded a new version of "File:Doripenem 5.jpg" current
- 20:1520:15, 26 December 2013 diff hist 0 File:Imipenem Cilastatin 3.jpg ShiSheng uploaded a new version of "File:Imipenem Cilastatin 3.jpg" current
- 20:1520:15, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 2.jpg No edit summary current
- 20:1420:14, 26 December 2013 diff hist 0 File:Imipenem Cilastatin 1.jpg ShiSheng uploaded a new version of "File:Imipenem Cilastatin 1.jpg" current
- 20:1420:14, 26 December 2013 diff hist 0 File:Doripenem 14.jpg ShiSheng uploaded a new version of "File:Doripenem 14.jpg" current
- 20:1320:13, 26 December 2013 diff hist 0 File:Doripenem 13.jpg ShiSheng uploaded a new version of "File:Doripenem 13.jpg" current
- 20:1320:13, 26 December 2013 diff hist 0 File:Doripenem 13.jpg ShiSheng uploaded a new version of "File:Doripenem 13.jpg"
- 20:1320:13, 26 December 2013 diff hist 0 File:Doripenem 12.jpg ShiSheng uploaded a new version of "File:Doripenem 12.jpg" current
- 20:1220:12, 26 December 2013 diff hist 0 File:Doripenem 11.jpg ShiSheng uploaded a new version of "File:Doripenem 11.jpg" current
- 20:1220:12, 26 December 2013 diff hist 0 File:Doripenem 11.jpg ShiSheng uploaded a new version of "File:Doripenem 11.jpg"
- 20:1120:11, 26 December 2013 diff hist 0 File:Doripenem 10.jpg ShiSheng uploaded a new version of "File:Doripenem 10.jpg" current
- 20:1120:11, 26 December 2013 diff hist 0 File:Doripenem 9x.jpg ShiSheng uploaded a new version of "File:Doripenem 9x.jpg" current
- 20:0720:07, 26 December 2013 diff hist 0 N File:Imipenem ilastatin 10.png No edit summary
- 20:0620:06, 26 December 2013 diff hist +424 Imipenem cilastatin No edit summary
- 19:5419:54, 26 December 2013 diff hist −389 Template:Imipenem cilastatin No edit summary
- 19:4819:48, 26 December 2013 diff hist −22 Imipenem cilastatin directions for use →Directions For Use
- 19:4819:48, 26 December 2013 diff hist +265 Imipenem cilastatin directions for use No edit summary
- 19:4619:46, 26 December 2013 diff hist −2 Imipenem cilastatin directions for use →Directions For Use
- 19:4619:46, 26 December 2013 diff hist −18 Imipenem cilastatin directions for use →Directions For Use
- 19:4419:44, 26 December 2013 diff hist +3,361 N Imipenem cilastatin directions for use Created page with "__NOTOC__ {{(imipenem cilastatin}} {{CMG}} ==Directions For Use== For IV Use Only. INSTRUCTIONS FOR USE To Open Diluent Container: Peel overwrap from the corner and remov..."
- 19:3419:34, 26 December 2013 diff hist +562 N Imipenem cilastatin labels and packages Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Labels and Packages== {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} ..."
- 19:2619:26, 26 December 2013 diff hist +1,262 N Imipenem cilastatin how supplied Created page with "__notoc__ {{(imipenem cilastatin}} {{CMG}} ==How Supplied== PRIMAXIN I.V. is supplied as a sterile powder mixture in single dose containers including vials and ADD-Vantage® ..."
- 19:1919:19, 26 December 2013 diff hist +1,747 N Imipenem cilastatin compatibility reconstitution and stability Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Compatibility Reconstitution And Stability== ===Compatibility And Stability=== Before Reconstitution: The dry powder should be ..."
- 19:0019:00, 26 December 2013 diff hist −4 Imipenem cilastatin dosage and administration No edit summary
- 18:5918:59, 26 December 2013 diff hist +6,282 N Imipenem cilastatin dosage and administration Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Dosage And Administration== ===Adults=== The dosage recommendations for PRIMAXIN I.V. represent the quantity of imipenem to be a..."
- 18:4718:47, 26 December 2013 diff hist +1,709 N Imipenem cilastatin overdosage Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Overdosage== The acute intravenous toxicity of imipenem-cilastatin sodium in a ratio of 1:1 was studied in mice at doses of 751 to..."
- 18:4318:43, 26 December 2013 diff hist +4,367 N Imipenem cilastatin adverse reactions Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Adverse Reactions== ===Adults=== PRIMAXIN I.V. is generally well tolerated. Many of the 1,723 patients treated in clinical trial..."
- 18:2918:29, 26 December 2013 diff hist +17,000 N Imipenem cilastatin warnings and precautions Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Warnings and Precautions== ===Warnings=== SERIOUS AND OCCASIONALLY FATAL HYPERSENSITIVITY (ANAPHYLACTIC) REACTIONS HAVE BEEN REPO..."
- 18:1818:18, 26 December 2013 diff hist −1 Imipenem cilastatin contraindications No edit summary
- 18:1818:18, 26 December 2013 diff hist +529 N Imipenem cilastatin contraindications Created page with "__NOTOC__ {{(imipenem cilastatin}} {{CMG}} ==Contraindications== PRIMAXIN I.V. is contraindicated in patients who have shown hypersensitivity to any component of this product..."
- 18:1418:14, 26 December 2013 diff hist +78 Imipenem cilastatin indications and usage →Indications And Usage
- 16:1516:15, 26 December 2013 diff hist +5,090 N Imipenem cilastatin indications and usage Created page with "__NOTOC__ {{(imipenem cilastatin}} {{CMG}} ==Indications And Usage== PRIMAXIN I.V. is indicated for the treatment of serious infections caused by susceptible strains of the ..."
- 15:5415:54, 26 December 2013 diff hist −5 Imipenem cilastatin microbiology No edit summary
- 15:5315:53, 26 December 2013 diff hist 0 Imipenem cilastatin microbiology →Quality Control
- 15:5215:52, 26 December 2013 diff hist +7,447 N Imipenem cilastatin microbiology Created page with "__NOTOC__ {{(Imipenem cilastatin}} {{CMG}} ==Microbiology== The bactericidal activity of Imipenem results from the inhibition of cell wall synthesis. Its greatest aff..."
- 15:4915:49, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 3.jpg No edit summary
- 15:1815:18, 26 December 2013 diff hist +2,906 N Imipenem cilastatin clinical pharmacology Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Imipenem Cilastatin== ===Adults=== ====Intravenous Administration==== Intravenous infusion of PRIMAXIN I.V. over 20 minutes res..."
- 15:1315:13, 26 December 2013 diff hist −884 Imipenem cilastatin No edit summary
- 15:0415:04, 26 December 2013 diff hist +2,212 N Imipenem cilastatin description Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Description== PRIMAXIN I.V. (Imipenem and Cilastatin for Injection) is a sterile formulation of imipenem (a thienamycin antibiotic) and cila..."
- 15:0115:01, 26 December 2013 diff hist 0 N File:Imipenem Cilastatin 1.jpg No edit summary
- 14:5014:50, 26 December 2013 diff hist +2 Template:Imipenem cilastatin No edit summary
- 14:4314:43, 26 December 2013 diff hist +2,597 N Template:Imipenem cilastatin Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 14:2414:24, 26 December 2013 diff hist 0 File:Doripenem 13.jpg ShiSheng uploaded a new version of "File:Doripenem 13.jpg"
- 14:0414:04, 26 December 2013 diff hist 0 File:Doripenem 10.jpg ShiSheng uploaded a new version of "File:Doripenem 10.jpg"
- 14:0214:02, 26 December 2013 diff hist 0 N File:Doripenem 9x.jpg No edit summary
- 13:0513:05, 26 December 2013 diff hist 0 File:Doripenem 10.jpg ShiSheng uploaded a new version of "File:Doripenem 10.jpg"
- 13:0413:04, 26 December 2013 diff hist 0 File:Doripenem 9.jpg ShiSheng uploaded a new version of "File:Doripenem 9.jpg" current
- 04:0504:05, 26 December 2013 diff hist +20 Doripenem →Mechanism of Action
- 04:0404:04, 26 December 2013 diff hist +439 Doripenem →Mechanism of Action
- 04:0004:00, 26 December 2013 diff hist +22 Doripenem warnings and precautions No edit summary
- 03:5003:50, 26 December 2013 diff hist +4 Doripenem indications and usage No edit summary
- 03:4303:43, 26 December 2013 diff hist +181 Doripenem microbiology No edit summary
- 03:3003:30, 26 December 2013 diff hist +500 N Doripenem labels and packages Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Labels And Packages== {| |- |thumb|800px|left |- |} {| |- |thumb|800px|left |- |}<ref>{..."
- 03:2903:29, 26 December 2013 diff hist 0 N File:Doripenem 14.jpg No edit summary
- 03:2903:29, 26 December 2013 diff hist 0 N File:Doripenem 13.jpg No edit summary
- 03:2503:25, 26 December 2013 diff hist +957 N Doripenem how supplied Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==How Supplied== DORIBAX® is supplied as single use type 1 clear glass vials containing 250 mg or 500 mg (on an anhydrous basis) of sterile d..."
- 03:2003:20, 26 December 2013 diff hist −1 Doripenem dosage and administration →Recommended Dosage
- 03:1903:19, 26 December 2013 diff hist 0 N File:Doripenem 9.jpg No edit summary
- 03:1803:18, 26 December 2013 diff hist +4,513 N Doripenem dosage and administration Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Dosage And Administration==、 ===Recommended Dosage=== The recommended dosage of DORIBAX® is 500 mg administered every 8 hours by intrav..."
- 03:1503:15, 26 December 2013 diff hist 0 N File:Doripenem 12.jpg No edit summary
- 03:1203:12, 26 December 2013 diff hist 0 N File:Doripenem 11.jpg No edit summary
- 03:1003:10, 26 December 2013 diff hist 0 File:Doripenem 10.jpg ShiSheng uploaded a new version of "File:Doripenem 10.jpg"
- 03:0803:08, 26 December 2013 diff hist 0 N File:Doripenem 10.jpg No edit summary
- 02:5502:55, 26 December 2013 diff hist 0 N File:Doripenem 8.jpg No edit summary current
- 02:5102:51, 26 December 2013 diff hist +3,740 N Doripenem clinical studies Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Clinical Studies== ===Complicated Intra-Abdominal Infections=== A total of 946 adults with complicated intra-abdominal infections were ran..."
- 02:4602:46, 26 December 2013 diff hist 0 N File:Doripenem 7.jpg No edit summary current
- 02:4502:45, 26 December 2013 diff hist 0 N File:Doripenem 6.jpg No edit summary current
- 02:3502:35, 26 December 2013 diff hist +844 N Doripenem overdosage Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Overdosage== In the event of overdose, DORIBAX® should be discontinued and general supportive treatment given. Doripenem can be removed by..."
- 02:3102:31, 26 December 2013 diff hist 0 Doripenem adverse reactions →Adverse Reactions from Clinical Trial
- 02:3002:30, 26 December 2013 diff hist +5 Doripenem adverse reactions →Postmarketing Experience
- 02:3002:30, 26 December 2013 diff hist +2,867 N Doripenem adverse reactions Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Adverse Reactions== ===Adverse Reactions from Clinical Trial=== Because clinical trials are conducted under widely varying conditions, adve..."
- 02:2702:27, 26 December 2013 diff hist 0 N File:Doripenem 5.jpg No edit summary
- 02:2202:22, 26 December 2013 diff hist +4,309 N Doripenem warnings and precautions Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Warnings And Precautions== ===Hypersensitivity Reactions=== Serious and occasionally fatal hypersensitivity (anaphylactic) and serious ski..."
- 02:1802:18, 26 December 2013 diff hist −2 Doripenem contraindications No edit summary
- 02:1702:17, 26 December 2013 diff hist +591 N Doripenem contraindications Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Contraindications== DORIBAX® is contraindicated in patients with known serious hypersensitivity to doripenem or to other drugs in the same..."
- 02:1602:16, 26 December 2013 diff hist +1,741 N Doripenem indications and usage Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Indications And Usage== To reduce the development of drug-resistant bacteria and maintain the effectiveness of DORIBAX® and other antibacte..."
- 02:1202:12, 26 December 2013 diff hist 0 Doripenem description →Description
- 02:1102:11, 26 December 2013 diff hist 0 Doripenem clinical pharmacology →Plasma Concentrations
- 02:1102:11, 26 December 2013 diff hist +1 Doripenem clinical pharmacology →Drug Interactions
- 02:1002:10, 26 December 2013 diff hist −1 Doripenem microbiology →Susceptibility Test Methods
- 02:0902:09, 26 December 2013 diff hist +3 Doripenem microbiology →Quality Control
- 02:0402:04, 26 December 2013 diff hist +5,399 N Doripenem microbiology Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Microbiology== ===Mechanism of Action=== Doripenem belongs to the carbapenem class of antimicrobials. Doripenem exerts its bactericidal act..."
- 02:0102:01, 26 December 2013 diff hist 0 N File:Doripenem 4.jpg No edit summary current
- 01:5001:50, 26 December 2013 diff hist 0 Doripenem description No edit summary
- 01:4901:49, 26 December 2013 diff hist +8,337 N Doripenem clinical pharmacology Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Clinical Pharmacology== Doripenem is a carbapenem with in vitro antibacterial activity against aerobic and anaerobic Gram-positive and Gram-..."
- 01:4101:41, 26 December 2013 diff hist 0 N File:Doripenem 3.jpg No edit summary current
- 01:3401:34, 26 December 2013 diff hist 0 N File:Doripenem 2.jpg No edit summary current
- 01:3101:31, 26 December 2013 diff hist +243 Doripenem description No edit summary
- 01:2801:28, 26 December 2013 diff hist +1,046 N Doripenem description Created page with "__NOTOC__ {{Doripenem}} {{CMG}} ==Description== DORIBAX®, doripenem monohydrate for injection vials contain 500 mg of doripenem on an anhydrous basis, a white to slightly-ye..."
- 01:2701:27, 26 December 2013 diff hist 0 N File:Doripenem 1.jpg No edit summary current
- 01:2101:21, 26 December 2013 diff hist −843 Doripenem No edit summary
24 December 2013
- 18:5118:51, 24 December 2013 diff hist +2,076 N Template:Doripenem Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 16:5016:50, 24 December 2013 diff hist +372 Cefaclor →Mechanisms of Action
- 16:4016:40, 24 December 2013 diff hist +13 Cefaclor No edit summary
- 16:3716:37, 24 December 2013 diff hist −178 Template:Cefaclor No edit summary
- 16:3616:36, 24 December 2013 diff hist −59 Cefaclor No edit summary
- 16:3216:32, 24 December 2013 diff hist −109 Cefaclor No edit summary
- 16:3116:31, 24 December 2013 diff hist +450 N Cefaclor labels and packages Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Labels and Packages== {| |- |thumb|800px|left |- |}<ref>{{Cite web | last = |first = |title = http://www.accessdata..."
- 16:3116:31, 24 December 2013 diff hist 0 N File:Cefaclor 7.jpg No edit summary current
- 16:2916:29, 24 December 2013 diff hist +1,038 N Cefaclor how supplied Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==How Supplied== Cefaclor Capsule USP 250 mg (blue cap and pink body hard gelatin capsule containing white to slightly yellowish powder imprin..."
- 16:2516:25, 24 December 2013 diff hist +1,238 N Cefaclor dosage and administration Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Dosage and Administration== Cefaclor is administered orally. Adults -- The usual adult dosage is 250 mg every 8 hours. For more severe infec..."
- 16:2416:24, 24 December 2013 diff hist 0 N File:Cefaclor 6.jpg No edit summary current
- 16:1816:18, 24 December 2013 diff hist +2,810 N Cefaclor clinical studies Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Clinical Studies== DRUG & OR LABORATORY TEST INTERACTIONS Patients receiving cefaclor may show a false-positive reaction for glucose in the..."
- 16:1216:12, 24 December 2013 diff hist +2,020 N Cefaclor overdosage Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Overdosage== Signs and Symptoms - The toxic symptoms following an overdose of cefaclor may include nausea, vomiting, epigastric distress, and..."
- 16:0816:08, 24 December 2013 diff hist +5,258 N Cefaclor adverse reactions Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Adverse Reactions== Adverse effects considered to be related to therapy with cefaclor are listed below: Hypersensitivity reactions have bee..."
- 16:0616:06, 24 December 2013 diff hist +4,564 N Cefaclor warnings and precautions Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Warnings and Precautions== ===warnings=== BEFORE THERAPY WITH CEFACLOR IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER TH..."
- 16:0116:01, 24 December 2013 diff hist +492 N Cefaclor contraindications Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Contraindications== Cefaclor is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.<ref>{{Cite web | la..."
- 15:5915:59, 24 December 2013 diff hist +2,791 N Cefaclor indications and usage Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} Cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Otit..."
- 15:5215:52, 24 December 2013 diff hist +156 Cefaclor microbiology No edit summary
- 15:3715:37, 24 December 2013 diff hist +5,221 N Cefaclor microbiology Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Microbiology== In vitro tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis...."
- 15:3615:36, 24 December 2013 diff hist 0 N File:Cefaclor 5.jpg No edit summary current
- 15:3415:34, 24 December 2013 diff hist 0 N File:Cefaclor 4.jpg No edit summary current
- 15:3115:31, 24 December 2013 diff hist 0 N File:Cefaclor 3.jpg No edit summary current
- 15:2815:28, 24 December 2013 diff hist 0 N File:Cefaclor 2.jpg No edit summary current
- 15:2615:26, 24 December 2013 diff hist +251 Cefaclor description →Description
- 15:2515:25, 24 December 2013 diff hist +1,670 N Cefaclor clinical pharmacology Created page with "__NOTOC__ {{Cefaclor}} {{CMG}} ==Clinical Pharmacology== Cefaclor is well absorbed after oral administration to fasting subjects. Total absorption is the same whether the dr..."
- 15:2215:22, 24 December 2013 diff hist −1 Cefaclor description No edit summary
- 15:2115:21, 24 December 2013 diff hist +1,439 N Cefaclor description Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} ==Description== Cefaclor, USP is a semisynthetic cephalosporin antibiotic for oral administration. It is chemically designated as 3-chloro-7-..."
- 15:2015:20, 24 December 2013 diff hist 0 N File:Cefaclor 1.jpg No edit summary current
- 15:0015:00, 24 December 2013 diff hist −4,187 Cefaclor No edit summary
- 14:5714:57, 24 December 2013 diff hist +321 Ertapenem microbiology No edit summary
- 14:5514:55, 24 December 2013 diff hist −9 Ertapenem adverse reactions No edit summary
- 14:5314:53, 24 December 2013 diff hist −1 Ertapenem dosage and administration →Prophylactic Regimen in Adults
- 14:5314:53, 24 December 2013 diff hist +41 Ertapenem dosage and administration →Preparation and Reconstitution for Administration
- 14:5214:52, 24 December 2013 diff hist +24 Ertapenem labels and packages No edit summary
- 14:5114:51, 24 December 2013 diff hist +18 Ertapenem how supplied No edit summary
- 14:5114:51, 24 December 2013 diff hist +27 Ertapenem dosage and administration No edit summary
- 14:5014:50, 24 December 2013 diff hist +23 Ertapenem clinical studies No edit summary
- 14:4914:49, 24 December 2013 diff hist +16 Ertapenem overdosage No edit summary
- 14:4814:48, 24 December 2013 diff hist +17 Ertapenem adverse reactions No edit summary
- 14:4714:47, 24 December 2013 diff hist +15 Ertapenem No edit summary
- 14:4614:46, 24 December 2013 diff hist +26 Ertapenem warnings and precautions No edit summary
- 14:4414:44, 24 December 2013 diff hist +124 Ertapenem warnings and precautions No edit summary
- 14:4014:40, 24 December 2013 diff hist +23 Ertapenem contraindications No edit summary
- 14:4014:40, 24 December 2013 diff hist +26 Ertapenem indications and usage No edit summary
- 14:3914:39, 24 December 2013 diff hist +65 Ertapenem microbiology No edit summary
- 14:2814:28, 24 December 2013 diff hist +2,061 N Template:Cefaclor Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 03:2303:23, 24 December 2013 diff hist −100 Template:Ertapenem No edit summary
- 03:2103:21, 24 December 2013 diff hist −30 Ertapenem No edit summary
- 03:1803:18, 24 December 2013 diff hist +481 N Ertapenem labels and packages Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} {| |- |thumb|400px|left |- |} {| |- |thumb|400px|left |- |}<ref>{{Cite web | last = |f..."
- 03:1803:18, 24 December 2013 diff hist 0 N File:Ertapenem 17.jpg No edit summary current
- 03:1603:16, 24 December 2013 diff hist 0 N File:Ertapenem 16.jpg No edit summary current
- 03:1403:14, 24 December 2013 diff hist +839 N Ertapenem how supplied Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} INVANZ is supplied as a sterile lyophilized powder in single dose vials containing ertapenem for intravenous infusion or for intramuscular i..."
- 03:0403:04, 24 December 2013 diff hist +5,898 N Ertapenem dosage and administration Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} <div>==== Instructions for Use in All Patients==== For Intravenous or Intramuscular Use DO NOT MIX OR CO-INFUSE INVANZ WITH OTHER MEDICATION..."
- 02:3902:39, 24 December 2013 diff hist 0 N File:Ertapenem 15.jpg No edit summary current
- 02:3702:37, 24 December 2013 diff hist 0 N File:Ertapenem 14.jpg No edit summary current
- 02:3402:34, 24 December 2013 diff hist +11,198 N Ertapenem clinical studies Created page with "__NOTOC__ {{Ertapenem}}{{CMG}} ====Adults==== Complicated Intra-Abdominal Infections Ertapenem was evaluated in adults for the treatment of complicated intra-abdominal infe..."
- 02:3002:30, 24 December 2013 diff hist +1,155 N Ertapenem overdosage Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} No specific information is available on the treatment of overdosage with INVANZ. Intentional overdosing of INVANZ is unlikely. Intravenous adm..."
- 02:2902:29, 24 December 2013 diff hist 0 Ertapenem adverse reactions No edit summary
- 02:2802:28, 24 December 2013 diff hist +11,101 N Ertapenem adverse reactions Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} == ====Clinical Trials Experience==== == Because clinical trials are conducted under widely varying conditions, adverse reaction rates observ..."
- 02:2502:25, 24 December 2013 diff hist 0 N File:Ertapenem 13.jpg No edit summary current
- 02:2102:21, 24 December 2013 diff hist 0 N File:Ertapenem 12.jpg No edit summary current
- 02:1902:19, 24 December 2013 diff hist 0 N File:Ertapenem 11.jpg No edit summary current
- 02:1702:17, 24 December 2013 diff hist 0 N File:Ertapenem 10.jpg No edit summary current
- 02:1402:14, 24 December 2013 diff hist 0 N File:Ertapenem 9.jpg No edit summary current
- 02:0602:06, 24 December 2013 diff hist +4,920 N Ertapenem warnings and precautions Created page with "====Hypersensitivity Reactions==== Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams..."
- 02:0002:00, 24 December 2013 diff hist +758 N Ertapenem contraindications Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} *INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in ..."
- 01:5601:56, 24 December 2013 diff hist +242 Ertapenem indications and usage No edit summary
- 01:5401:54, 24 December 2013 diff hist +3,204 N Ertapenem indications and usage Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} To reduce the development of drug-resistant bacteria and maintain the effectiveness of INVANZ® and other antibacterial drugs, INVANZ should b..."
- 01:4601:46, 24 December 2013 diff hist 0 N File:Ertapenem 8.jpg No edit summary current
- 01:4201:42, 24 December 2013 diff hist 0 N File:Ertapenem 7.jpg No edit summary current
- 01:3801:38, 24 December 2013 diff hist −48 Ertapenem microbiology No edit summary
- 01:3601:36, 24 December 2013 diff hist +38 Ertapenem microbiology No edit summary
- 01:3401:34, 24 December 2013 diff hist +6,441 N Ertapenem microbiology Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} ====Gram-positive bacteria====: *Staphylococcus aureus (methicillin susceptible isolates only) *Streptococcus agalactiae *St..."
- 01:3001:30, 24 December 2013 diff hist 0 N File:Ertapenem 6.jpg No edit summary current
- 01:2301:23, 24 December 2013 diff hist 0 N File:Ertapenem 5.jpg No edit summary current
23 December 2013
- 21:4321:43, 23 December 2013 diff hist +9,021 N Ertapenem clinical pharmacology Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} Mechanism of Action Ertapenem sodium is a carbapenem antibiotic . Pharmacokinetics Average plasma concentrations (mcg/mL) of ertapenem follo..."
- 21:4121:41, 23 December 2013 diff hist 0 N File:Ertapenem 4.jpg No edit summary current
- 21:3721:37, 23 December 2013 diff hist 0 N File:Ertapenem 3.jpg No edit summary current
- 21:3421:34, 23 December 2013 diff hist 0 N File:Ertapenem 2.jpg No edit summary current
- 21:3021:30, 23 December 2013 diff hist +1,719 N Ertapenem description Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} INVANZ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1-β methyl-carbapenem that is structurally related to beta-lactam antib..."
- 21:2721:27, 23 December 2013 diff hist 0 N File:Ertapenem 1.jpg No edit summary current
- 21:1921:19, 23 December 2013 diff hist −2,583 Ertapenem No edit summary
- 20:4320:43, 23 December 2013 diff hist +2,172 N Template:Ertapenem Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 20:4220:42, 23 December 2013 diff hist −10 Template:Meropenem No edit summary
- 20:4120:41, 23 December 2013 diff hist 0 Template:Meropenem No edit summary
- 20:3220:32, 23 December 2013 diff hist 0 Cefdinir warnings No edit summary
- 20:2820:28, 23 December 2013 diff hist +236 Cefdinir labels and packages No edit summary
- 20:2820:28, 23 December 2013 diff hist +236 Cefdinir how supplied No edit summary
- 20:2720:27, 23 December 2013 diff hist +236 Cefdinir dosage and administration No edit summary
- 20:2620:26, 23 December 2013 diff hist +236 Cefdinir clinical studies No edit summary
- 20:2520:25, 23 December 2013 diff hist −1 Cefdinir adverse reactions No edit summary
- 20:2420:24, 23 December 2013 diff hist +236 Cefdinir adverse reactions No edit summary
- 20:2320:23, 23 December 2013 diff hist +236 Cefdinir overdosage No edit summary
- 20:2220:22, 23 December 2013 diff hist +237 Cefdinir precautions No edit summary
- 20:2020:20, 23 December 2013 diff hist +275 Cefdinir warnings No edit summary
- 20:1320:13, 23 December 2013 diff hist +208 Cefdinir contraindications No edit summary
- 20:1220:12, 23 December 2013 diff hist +492 Cefdinir indications and usage No edit summary
- 20:0420:04, 23 December 2013 diff hist +625 Cefdinir microbiology No edit summary
- 19:5219:52, 23 December 2013 diff hist 0 Cefdinir clinical pharmacology No edit summary
- 19:5119:51, 23 December 2013 diff hist +379 Cefdinir clinical pharmacology No edit summary
- 19:2419:24, 23 December 2013 diff hist +13 Cefdinir description No edit summary
- 19:1819:18, 23 December 2013 diff hist +282 Cefdinir description No edit summary
- 18:4518:45, 23 December 2013 diff hist −1 Cefdinir description No edit summary
- 18:4418:44, 23 December 2013 diff hist +172 N Cefdinir labels and packages Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} {| |- |thumb|400px|left |- |} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect"
- 18:4218:42, 23 December 2013 diff hist 0 N File:Cefdinir 14.jpg No edit summary current
- 18:4018:40, 23 December 2013 diff hist +526 N Cefdinir how supplied Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} Cefdinir capsules USP, 300 mg, size ‘0’ capsules having blue cap imprinted twice with "LUPIN" (in black ink) and purple body imprinted twic..."
- 18:3318:33, 23 December 2013 diff hist +2,170 N Cefdinir dosage and administration Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} The recommended dosage and duration of treatment for infections in adults and adolescents are described in the following chart; the total daily..."
- 18:2818:28, 23 December 2013 diff hist 0 N File:Cefdinir 13.jpg No edit summary current
- 18:2518:25, 23 December 2013 diff hist 0 N File:Cefdinir 12.jpg No edit summary current
- 18:2418:24, 23 December 2013 diff hist 0 N File:Cefdinir 11.jpg No edit summary current
- 18:2318:23, 23 December 2013 diff hist 0 N File:Cefdinir 10.jpg No edit summary current
- 18:2318:23, 23 December 2013 diff hist 0 N File:Cefdinir 9.jpg No edit summary current
- 18:2218:22, 23 December 2013 diff hist +2,041 N Cefdinir clinical studies Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} '''Community-Acquired Bacterial Pneumonia''': In a controlled, double-blind study in adults and adolescents conducted in the U.S., cefdinir BI..."
- 18:1018:10, 23 December 2013 diff hist +603 N Cefdinir overdosage Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} Information on cefdinir overdosage in humans is not available. In acute rodent toxicity studies, a single oral 5600 mg/kg dose produced no adve..."
- 18:0818:08, 23 December 2013 diff hist +67 Cefdinir adverse reactions No edit summary
- 18:0618:06, 23 December 2013 diff hist +3,518 N Cefdinir adverse reactions Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==ADVERSE EVENTS== Clinical Trials - (Adult and Adolescent Patients): In clinical trials, 5093 adult and adolescent patients (3841 U.S. and ..."
- 18:0518:05, 23 December 2013 diff hist 0 N File:Cefdinir 8.jpg No edit summary current
- 18:0118:01, 23 December 2013 diff hist 0 N File:Cefdinir 7.jpg No edit summary current
- 17:5617:56, 23 December 2013 diff hist +7,682 N Cefdinir precautions Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ''''General'''': Prescribing cefdinir capsules in the absence of a proven or strongly suspected bacterial infection or a prophylactic indic..."
- 17:5117:51, 23 December 2013 diff hist +2,049 N Cefdinir warnings Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Cefdinir warnings== BEFORE THERAPY WITH CEFDINIR IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD P..."
- 17:4617:46, 23 December 2013 diff hist +253 N Cefdinir contraindications Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Cefdinir contraindications== Cefdinir is contraindicated in patients with known allergy to the cephalosporin class of antibiotics. ==Refe..."
- 17:4017:40, 23 December 2013 diff hist +3,202 N Cefdinir indications and usage Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Cefdinir indications and usage== To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir capsules a..."
- 17:3817:38, 23 December 2013 diff hist +5,618 Cefdinir microbiology No edit summary
- 17:2717:27, 23 December 2013 diff hist +9 N Cefdinir microbiology Created page with "fafsadfas"
- 17:2417:24, 23 December 2013 diff hist −29 Cefdinir No edit summary
- 16:4416:44, 23 December 2013 diff hist 0 N File:Cefdinir 6.jpg No edit summary current
- 16:4116:41, 23 December 2013 diff hist 0 N File:Cefdinir 5.jpg No edit summary current
- 16:3816:38, 23 December 2013 diff hist 0 N File:Cefdinir 4.jpg No edit summary current
- 16:3416:34, 23 December 2013 diff hist 0 N File:Cefdinir 3.jpg No edit summary current
- 16:2816:28, 23 December 2013 diff hist +6,979 Cefdinir clinical pharmacology No edit summary
- 16:2416:24, 23 December 2013 diff hist +16 N Cefdinir clinical pharmacology Created page with "FAGSGKFPOASGFASD"
- 16:1816:18, 23 December 2013 diff hist +803 Cefdinir No edit summary
- 16:1316:13, 23 December 2013 diff hist −2,912 Cefdinir No edit summary
- 16:1116:11, 23 December 2013 diff hist 0 Template:Cefdinir No edit summary
- 16:1016:10, 23 December 2013 diff hist 0 Template:Cefdinir No edit summary
- 15:5015:50, 23 December 2013 diff hist 0 N File:Cefdinir 2.jpg No edit summary current
- 15:4015:40, 23 December 2013 diff hist −4 Cefdinir description No edit summary
- 15:4015:40, 23 December 2013 diff hist +974 N Cefdinir description Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Cefdinir description== Cefdinir capsules contains the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, fo..."
- 15:2115:21, 23 December 2013 diff hist +2,153 N Template:Cefdinir Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 15:2115:21, 23 December 2013 diff hist +2,298 N Cephapirin sodium Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..." current
- 13:3713:37, 23 December 2013 diff hist +2,446 N Template:Vancomycin Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
- 13:3513:35, 23 December 2013 diff hist −2,443 Template:Moxalactam Blanked the page current
- 13:1213:12, 23 December 2013 diff hist −22 Template:Moxalactam No edit summary
- 13:1113:11, 23 December 2013 diff hist +2,465 N Template:Moxalactam Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
21 December 2013
- 05:1005:10, 21 December 2013 diff hist +32 Meropenem microbiology →Microbiology
- 04:4904:49, 21 December 2013 diff hist +7 Meropenem microbiology →Microbiology
- 04:4604:46, 21 December 2013 diff hist −9 Meropenem →Mechanism of action
- 04:3804:38, 21 December 2013 diff hist 0 N File:Meropenem brand 7.jpeg No edit summary current
- 04:3704:37, 21 December 2013 diff hist +1,122 N Meropenem labels and packages Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Labels and Packages== {| |- |thumb|400px|left |- |} {| |- |thumb|400px|left ..."
- 04:3404:34, 21 December 2013 diff hist 0 File:Meropenem brand 7.jpg ShiSheng uploaded a new version of "File:Meropenem brand 7.jpg" current
- 04:2304:23, 21 December 2013 diff hist 0 N File:Meropenem brand12.jpg No edit summary current
- 04:2204:22, 21 December 2013 diff hist 0 N File:Meropenem brand11.jpg No edit summary current
- 04:2204:22, 21 December 2013 diff hist 0 N File:Meropenem brand10.jpg No edit summary current
- 04:2104:21, 21 December 2013 diff hist 0 File:Meropenem 10.jpg ShiSheng uploaded a new version of "File:Meropenem 10.jpg" current
- 04:2004:20, 21 December 2013 diff hist 0 File:Meropenem brand9.jpg ShiSheng uploaded a new version of "File:Meropenem brand9.jpg" current
- 04:2004:20, 21 December 2013 diff hist 0 N File:Meropenem brand9.jpg No edit summary
- 04:1904:19, 21 December 2013 diff hist 0 N File:Meropenem brand8.jpg No edit summary current
- 04:1804:18, 21 December 2013 diff hist 0 N File:Meropenem brand 7.jpg No edit summary
- 04:1804:18, 21 December 2013 diff hist 0 N File:Meropenem brand6.jpg No edit summary current
- 04:1704:17, 21 December 2013 diff hist 0 N File:Meropenem brand5.jpg No edit summary current
- 04:1504:15, 21 December 2013 diff hist 0 N File:Meropenem brand4.jpg No edit summary current
- 04:1404:14, 21 December 2013 diff hist 0 N File:Meropenem brand3.jpg No edit summary current
- 04:1404:14, 21 December 2013 diff hist 0 N File:Meropenem brand2.jpg No edit summary current
- 04:1204:12, 21 December 2013 diff hist 0 N File:Meropenem brand1.jpg No edit summary current
20 December 2013
- 22:5822:58, 20 December 2013 diff hist +218 Meropenem microbiology No edit summary
- 22:4522:45, 20 December 2013 diff hist +6,494 Meropenem microbiology →Microbiology
- 22:4422:44, 20 December 2013 diff hist 0 N File:Meropenem 12.jpg No edit summary current
- 22:4122:41, 20 December 2013 diff hist 0 N File:Meropenem 11.jpg No edit summary current
- 22:1922:19, 20 December 2013 diff hist +332 Meropenem clinical studies No edit summary
- 22:1822:18, 20 December 2013 diff hist +332 Meropenem overdosage No edit summary
- 22:1722:17, 20 December 2013 diff hist +321 Meropenem adverse reactions No edit summary
- 22:1522:15, 20 December 2013 diff hist +333 Meropenem precautions No edit summary
- 22:1022:10, 20 December 2013 diff hist +332 Meropenem warnings No edit summary
- 22:0922:09, 20 December 2013 diff hist +331 Meropenem contraindications No edit summary
- 22:0822:08, 20 December 2013 diff hist +303 Meropenem indications and usage No edit summary
- 21:5021:50, 20 December 2013 diff hist −1 Meropenem microbiology No edit summary
- 21:5021:50, 20 December 2013 diff hist +368 Meropenem microbiology No edit summary
- 21:4821:48, 20 December 2013 diff hist +330 Meropenem clinical pharmacology No edit summary
- 21:4221:42, 20 December 2013 diff hist +67 Meropenem clinical pharmacology No edit summary
- 21:1521:15, 20 December 2013 diff hist +727 N Meropenem how supplied Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==HOW SUPPLIED== MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intrav..."
- 21:0221:02, 20 December 2013 diff hist +3,474 N Meropenem compatibility reconstitution and stability Created page with "__NOTOC__ {{Meropenem}} {{CMG}} == Compatibility, Reconstitution, and Stability== Compatibility of MERREM I.V. with other drugs has not been established.MERREM I.V. should n..."
- 20:5620:56, 20 December 2013 diff hist 0 N File:Meropenem 10.jpg No edit summary
- 20:2020:20, 20 December 2013 diff hist −1,169 Template:Meropenem No edit summary
- 20:1020:10, 20 December 2013 diff hist +3,438 N Meropenem dosage and administration Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==DOSAGE AND ADMINISTRATION== ===Adults:=== The recommended dose of Meropenem is 500 mg given every 8 hours for skin and skin structure in..."
- 19:5919:59, 20 December 2013 diff hist 0 N File:Meropenem 7x.jpg No edit summary current
- 19:5019:50, 20 December 2013 diff hist 0 N File:Meropenem 9.jpg No edit summary current
- 19:4719:47, 20 December 2013 diff hist 0 N File:Meropenem 8.jpg No edit summary current
- 19:4219:42, 20 December 2013 diff hist 0 N File:Meropenem 7.jpg No edit summary current
- 19:3319:33, 20 December 2013 diff hist 0 N File:Meropenem 6.jpg No edit summary current
- 19:3019:30, 20 December 2013 diff hist +134 Meropenem clinical studies No edit summary
- 19:0819:08, 20 December 2013 diff hist +12 Meropenem clinical studies →Skin and Skin Structure
- 19:0419:04, 20 December 2013 diff hist +6,164 N Meropenem clinical studies Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Clinical Studies== ===Skin and Skin Structure=== Adult patients with complicated skin and skin structure infections including complicated c..."
- 18:5018:50, 20 December 2013 diff hist 0 N File:Meropenem 5.jpg No edit summary current
- 18:4518:45, 20 December 2013 diff hist 0 N File:Meropenem 4.jpg No edit summary current
- 18:3918:39, 20 December 2013 diff hist 0 N File:Meropenem 3.jpg No edit summary current
- 18:3318:33, 20 December 2013 diff hist 0 N File:Meropenem 2.jpg No edit summary current
- 18:2618:26, 20 December 2013 diff hist 0 N File:Meropenem clinical.jpg No edit summary current
- 17:1217:12, 20 December 2013 diff hist +1,159 N Meropenem overdosage Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Overdosage== In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, ..."
- 17:0017:00, 20 December 2013 diff hist +6,654 N Meropenem adverse reactions Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Adverse Reactions == ===Adult Patients: === During clinical investigations, 2904 immunocompetent adult patients were treated for infections..."
- 16:4716:47, 20 December 2013 diff hist +8,424 N Meropenem precautions Created page with " _NOTOC__ {{Meropenem}} {{CMG}} ==Precaution== ===General: === Prescribing Meropenem in the absence of a proven or strongly suspected bacterial infection or a prophylactic in..."
- 15:5715:57, 20 December 2013 diff hist +2,283 N Meropenem warnings Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Warnings== Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy wit..."
- 14:4414:44, 20 December 2013 diff hist +274 N Meropenem contraindications Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Contraindications== Meropenem I.V. is contraindicated in patients with known hypersensitivity to any component of this product or to other..."
- 14:3414:34, 20 December 2013 diff hist −4 Meropenem indications and usage →Indications and Usage
- 14:3314:33, 20 December 2013 diff hist +4 Meropenem indications and usage →Bacterial Meningitis (Pediatric patients > 3 months only)
- 14:2914:29, 20 December 2013 diff hist +2,755 N Meropenem indications and usage Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Indications and Usage== To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem I.V. and other ant..."
19 December 2013
- 20:4020:40, 19 December 2013 diff hist −14 Meropenem microbiology →Microbiology
- 20:3420:34, 19 December 2013 diff hist +1,232 N Meropenem microbiology Created page with "==Microbiology== Meropenem is a broad-spectrum Carbapenem antibiotic. It is active against Gram-positive and Gram- negative bacteria. The bactericidal activity of me..."
- 20:3120:31, 19 December 2013 diff hist +3,307 N Meropenem clinical pharmacology Created page with "At the end of a 30-minute intravenous infusion of a single dose of MERREM I.V. in normal volunteers, mean peak plasma concentrations are approximately 23 µg/mL (range 14-26..."
- 20:1720:17, 19 December 2013 diff hist 0 N File:Meropenem Concentrations.jpg No edit summary current
- 19:5819:58, 19 December 2013 diff hist +1,180 N Meropenem description Created page with "Meropenem for Injection, USP (I.V.) is a sterile, pyrogen-free, synthetic, broad-spectrum, carbapenem antibiotic for intravenous administration. It is (4R,5S,6S)-3-(3S,5S)-5..."
- 19:5519:55, 19 December 2013 diff hist 0 N File:Meropenem.jpg No edit summary current
- 19:4819:48, 19 December 2013 diff hist +738 Template:Meropenem →Mechanisms of Action
- 19:4319:43, 19 December 2013 diff hist +1,199 Template:Meropenem No edit summary
- 19:1619:16, 19 December 2013 diff hist −769 Template:Meropenem No edit summary
- 18:5818:58, 19 December 2013 diff hist −2 Template:Meropenem No edit summary
- 18:5118:51, 19 December 2013 diff hist +2,440 N Template:Meropenem Created page with " {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#696..."
- 18:4018:40, 19 December 2013 diff hist −224 Sandbox/20 →Pathogen-Specific Therapy
- 17:2717:27, 19 December 2013 diff hist +154 Sandbox/20 →Pathogen-Specific Therapy
- 17:1317:13, 19 December 2013 diff hist +362 Sandbox/20 →Negative CSF Gram Stain
- 04:4404:44, 19 December 2013 diff hist +198 Sandbox/20 →Negative CSF Gram Stain
18 December 2013
- 22:3022:30, 18 December 2013 diff hist +253 Sandbox/20 →Negative CSF Gram Stain
- 22:1922:19, 18 December 2013 diff hist +4 Sandbox/20 →Postive CSF Gram Stain
- 22:1322:13, 18 December 2013 diff hist +130 Sandbox/20 →Postive CSF Gram Stain
- 21:4721:47, 18 December 2013 diff hist +401 Sandbox/20 →Pathogen-Specific Therapy
- 21:1821:18, 18 December 2013 diff hist +8 Sandbox/20 →Negative CSF Gram Stain
- 21:1621:16, 18 December 2013 diff hist −443 Sandbox/20 →Negative CSF Gram Stain
- 21:1421:14, 18 December 2013 diff hist −967 Sandbox/20 →Bacteria Meningitis in Neonate
- 21:1321:13, 18 December 2013 diff hist +687 Sandbox/20 →Postive CSF Gram Stain
- 21:0921:09, 18 December 2013 diff hist +971 Sandbox/20 →Postive CSF Gram Stain
- 19:2019:20, 18 December 2013 diff hist −4 Sandbox/20 →Pathogen-Specific Therapy
- 18:1918:19, 18 December 2013 diff hist +274 Sandbox/20 →Pathogen-Specific Therapy
- 18:0818:08, 18 December 2013 diff hist −48 Sandbox/20 →Postive CSF Gram Stain
- 17:4917:49, 18 December 2013 diff hist +1,554 Sandbox/20 →Empiric Therapy
- 03:4003:40, 18 December 2013 diff hist −77 Sandbox/20 →Pathogen-Specific Therapy
17 December 2013
- 19:2419:24, 17 December 2013 diff hist +804 Sandbox/20 →Pathogen-Specific Therapy
- 18:3918:39, 17 December 2013 diff hist +8 Sandbox/20 →Pathogen-Specific Therapy
- 18:1418:14, 17 December 2013 diff hist +280 Sandbox/20 →Pathogen-Specific Therapy
16 December 2013
- 22:0122:01, 16 December 2013 diff hist +57 Sandbox/20 →Pathogen-Specific Therapy
- 21:3621:36, 16 December 2013 diff hist +440 Sandbox/20 →Negative CSF Gram Stain
- 21:1321:13, 16 December 2013 diff hist +7 Sandbox/20 →Negative CSF Gram Stain
- 20:5520:55, 16 December 2013 diff hist +38 Sandbox/20 →Empiric Therapy
- 20:1420:14, 16 December 2013 diff hist −1,622 Sandbox/20 →Specific Therapy—Positive culture of CSF with in vitro susceptibility results available
- 20:1420:14, 16 December 2013 diff hist +2,439 Sandbox/20 →Pathogen-Specific Therapy
- 16:2116:21, 16 December 2013 diff hist +1,589 Sandbox/20 →Positive CSF Gram Stain
- 04:2404:24, 16 December 2013 diff hist +4,330 Sandbox/20 →Negative CSF Gram Stain
13 December 2013
- 15:3315:33, 13 December 2013 diff hist +60 Sandbox/20 →Negative CSF Gram Stain
- 15:2215:22, 13 December 2013 diff hist +28 Sandbox/20 →Negative CSF Gram Stain
11 December 2013
- 20:3320:33, 11 December 2013 diff hist −21 Vertebrobasilar insufficiency surgery →Indications for Surgery current
- 20:3220:32, 11 December 2013 diff hist −3 Vertebrobasilar insufficiency surgery →Indications for Surgery
- 20:3120:31, 11 December 2013 diff hist +1,248 Vertebrobasilar insufficiency surgery No edit summary
- 19:1319:13, 11 December 2013 diff hist −2 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis current
- 19:1219:12, 11 December 2013 diff hist +558 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 18:4318:43, 11 December 2013 diff hist +2,183 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 18:2018:20, 11 December 2013 diff hist +18 Vertebrobasilar insufficiency differential diagnosis →Differentiating Vertebral Artery Disease from other Diseases current
- 18:1218:12, 11 December 2013 diff hist +9 Vertebrobasilar insufficiency differential diagnosis →Differentiating Vertebral Artery Disease from other Diseases
- 15:5315:53, 11 December 2013 diff hist +39 Vertebrobasilar insufficiency historical perspective →Overview current
- 06:1206:12, 11 December 2013 diff hist +760 Vertebrobasilar insufficiency other imaging findings →DSA current
- 06:0506:05, 11 December 2013 diff hist −119 Vertebrobasilar insufficiency historical perspective →Overview
- 05:5605:56, 11 December 2013 diff hist +2 Vertebrobasilar insufficiency medical therapy →Medical Therapy current
- 05:5505:55, 11 December 2013 diff hist −2,779 Vertebrobasilar insufficiency medical therapy No edit summary
- 05:3405:34, 11 December 2013 diff hist +7 Vertebrobasilar insufficiency primary prevention No edit summary current
- 05:3105:31, 11 December 2013 diff hist −2 Vertebrobasilar insufficiency primary prevention →Overview
- 05:3005:30, 11 December 2013 diff hist +87 Vertebrobasilar insufficiency primary prevention →Overview
- 05:2705:27, 11 December 2013 diff hist +1,489 Vertebrobasilar insufficiency primary prevention No edit summary
10 December 2013
- 18:0618:06, 10 December 2013 diff hist −17 Vertebrobasilar insufficiency historical perspective →Development of Treatment Strategies
- 16:5316:53, 10 December 2013 diff hist 0 Vertebrobasilar insufficiency other imaging findings →DSA
- 16:5316:53, 10 December 2013 diff hist 0 Vertebrobasilar insufficiency CT No edit summary current
- 16:5216:52, 10 December 2013 diff hist +20 Vertebrobasilar insufficiency MRI No edit summary
- 16:5016:50, 10 December 2013 diff hist +20 Vertebrobasilar insufficiency CT No edit summary
- 16:4516:45, 10 December 2013 diff hist +58 Vertebrobasilar insufficiency other imaging findings No edit summary
- 16:4416:44, 10 December 2013 diff hist 0 N File:Basilar artery.jpg No edit summary current
- 16:3716:37, 10 December 2013 diff hist +37 Vertebrobasilar insufficiency CT No edit summary
- 16:3116:31, 10 December 2013 diff hist 0 N File:CT of vertebrobasilar.jpg No edit summary current
- 16:2816:28, 10 December 2013 diff hist +43 Vertebrobasilar insufficiency MRI No edit summary
9 December 2013
- 21:5821:58, 9 December 2013 diff hist +1,490 Vertebrobasilar insufficiency other imaging findings →DSA
- 21:2621:26, 9 December 2013 diff hist +110 Vertebrobasilar insufficiency MRI →Overview
- 21:1921:19, 9 December 2013 diff hist +505 Vertebrobasilar insufficiency MRI →MRI
- 21:1621:16, 9 December 2013 diff hist +612 Vertebrobasilar insufficiency MRI →MRI
- 20:4820:48, 9 December 2013 diff hist 0 File:CTA of VB.jpg ShiSheng uploaded a new version of "File:CTA of VB.jpg" current
- 20:3320:33, 9 December 2013 diff hist +578 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 20:1320:13, 9 December 2013 diff hist +92 Vertebrobasilar insufficiency CT →Overview
- 20:0520:05, 9 December 2013 diff hist +40 Vertebrobasilar insufficiency laboratory findings →Laboratory Findings current
- 20:0320:03, 9 December 2013 diff hist +5 Vertebrobasilar insufficiency risk factors →Overview current
- 20:0220:02, 9 December 2013 diff hist +19 Vertebrobasilar insufficiency risk factors No edit summary
- 19:4019:40, 9 December 2013 diff hist −74 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 19:3519:35, 9 December 2013 diff hist +733 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 18:2318:23, 9 December 2013 diff hist +3 Vertebrobasilar insufficiency natural history, complications and prognosis →Prognosis
- 18:1618:16, 9 December 2013 diff hist +263 Vertebrobasilar insufficiency natural history, complications and prognosis →Complications
6 December 2013
- 21:4221:42, 6 December 2013 diff hist +28 Thrombolysis →Uses current
- 04:1404:14, 6 December 2013 diff hist −1,029 Vertebrobasilar insufficiency No edit summary
- 03:5703:57, 6 December 2013 diff hist +208 Vertebrobasilar insufficiency →Laboratory Finding
- 03:4703:47, 6 December 2013 diff hist −6 Vertebrobasilar insufficiency →Development of Treatment Strategies
- 03:2903:29, 6 December 2013 diff hist +29 Vertebrobasilar insufficiency →Physical Examination
5 December 2013
- 21:3521:35, 5 December 2013 diff hist +73 Vertebrobasilar insufficiency →Diagnosis
- 21:0621:06, 5 December 2013 diff hist +117 Vertebrobasilar insufficiency →Prognosis
- 20:5220:52, 5 December 2013 diff hist +9 Vertebrobasilar insufficiency →Natural History
- 20:5120:51, 5 December 2013 diff hist +70 Vertebrobasilar insufficiency →Natural History
- 20:2520:25, 5 December 2013 diff hist +4 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 20:0620:06, 5 December 2013 diff hist +18 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 19:4719:47, 5 December 2013 diff hist −34 Vertebrobasilar insufficiency →Causes by Organ System
- 19:3819:38, 5 December 2013 diff hist +40 Vertebrobasilar insufficiency →Causes in Alphabetical Order
- 19:2719:27, 5 December 2013 diff hist −1 Vertebrobasilar insufficiency →Causes by Organ System
- 19:2619:26, 5 December 2013 diff hist +88 Vertebrobasilar insufficiency →Causes by Organ System
- 19:1019:10, 5 December 2013 diff hist +9 Vertebrobasilar insufficiency →Common Causes
- 19:0719:07, 5 December 2013 diff hist +13 Vertebrobasilar insufficiency →Life Threatening Causes
- 19:0419:04, 5 December 2013 diff hist +9 Vertebrobasilar insufficiency →Life Threatening Causes
- 18:5818:58, 5 December 2013 diff hist +13 Vertebrobasilar insufficiency →Overview
- 18:5718:57, 5 December 2013 diff hist +13 Vertebrobasilar insufficiency →Overview
- 18:5318:53, 5 December 2013 diff hist +117 Vertebrobasilar insufficiency →Pathophysiology
- 18:3918:39, 5 December 2013 diff hist +81 Vertebrobasilar insufficiency No edit summary
- 18:3118:31, 5 December 2013 diff hist −302 Vertebrobasilar insufficiency No edit summary
- 16:3616:36, 5 December 2013 diff hist +255 Vertebrobasilar insufficiency →The interventional therapy
- 16:1916:19, 5 December 2013 diff hist +197 Vertebrobasilar insufficiency →Causes
- 16:0716:07, 5 December 2013 diff hist −1 Vertebrobasilar insufficiency →Indications for Surgery
- 15:5015:50, 5 December 2013 diff hist +87 N File:CTA of VB.jpg The three-dimensional reconstruction of CTA clearly display the vertebrobasilar artery.
- 15:2415:24, 5 December 2013 diff hist +31 Vertebrobasilar insufficiency →Laboratory Finding
- 15:2215:22, 5 December 2013 diff hist +2,934 Vertebrobasilar insufficiency →Diagnosis
- 07:2707:27, 5 December 2013 diff hist −15 Vertebrobasilar insufficiency →Screening
- 06:5906:59, 5 December 2013 diff hist +563 Vertebrobasilar insufficiency →Natural History, Complications and Prognosis
- 06:3206:32, 5 December 2013 diff hist +14 Vertebrobasilar insufficiency →The interventional therapy
- 06:2906:29, 5 December 2013 diff hist +967 Vertebrobasilar insufficiency →Laboratory Finding
- 06:0006:00, 5 December 2013 diff hist +489 Vertebrobasilar insufficiency →Development of Treatment Strategies
- 05:1505:15, 5 December 2013 diff hist +32 Vertebrobasilar insufficiency →Surgery and Device Based Therapy
- 05:1405:14, 5 December 2013 diff hist +2,038 Vertebrobasilar insufficiency →Indications for Surgery
- 03:0503:05, 5 December 2013 diff hist +21 Vertebrobasilar insufficiency →Risk Factors
- 02:1302:13, 5 December 2013 diff hist +1,419 Vertebrobasilar insufficiency →overview
4 December 2013
- 21:3421:34, 4 December 2013 diff hist +6,102 Vertebrobasilar insufficiency No edit summary
- 18:4618:46, 4 December 2013 diff hist −562 Vertebrobasilar insufficiency →Historical Perspective
- 16:4416:44, 4 December 2013 diff hist +2,792 Vertebrobasilar insufficiency →Physical Examination
- 16:0716:07, 4 December 2013 diff hist +692 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 15:2315:23, 4 December 2013 diff hist +26 Vertebrobasilar insufficiency →overview
- 14:4814:48, 4 December 2013 diff hist −30 Vertebrobasilar insufficiency No edit summary
3 December 2013
- 22:3122:31, 3 December 2013 diff hist +770 Vertebrobasilar insufficiency →Historical Perspective
- 21:1521:15, 3 December 2013 diff hist +2,007 Vertebrobasilar insufficiency →Surgery and Device Based Therapy
- 20:4320:43, 3 December 2013 diff hist +586 Vertebrobasilar insufficiency →Risk Factors
- 20:0320:03, 3 December 2013 diff hist −13 Vertebrobasilar insufficiency →Pharmacotherapy
- 17:3117:31, 3 December 2013 diff hist −11 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 17:2917:29, 3 December 2013 diff hist +12 Vertebrobasilar insufficiency →Historical Perspective
- 17:2417:24, 3 December 2013 diff hist −20 Vertebrobasilar insufficiency →Classification
- 17:2217:22, 3 December 2013 diff hist +182 Vertebrobasilar insufficiency →Historical Perspective
- 16:5316:53, 3 December 2013 diff hist +208 Vertebrobasilar insufficiency →Pharmacotherapy
- 16:2516:25, 3 December 2013 diff hist +503 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 16:1316:13, 3 December 2013 diff hist +684 Vertebrobasilar insufficiency →Pathophysiology
- 15:5715:57, 3 December 2013 diff hist +1,487 Vertebrobasilar insufficiency →Pharmacotherapy
- 15:5115:51, 3 December 2013 diff hist +1,745 Vertebrobasilar insufficiency →Pharmacotherapy
2 December 2013
- 22:1722:17, 2 December 2013 diff hist +218 Vertebrobasilar insufficiency →Diagnosis
- 22:1022:10, 2 December 2013 diff hist +56 Vertebrobasilar insufficiency →Risk Factors
- 21:1221:12, 2 December 2013 diff hist −14 Vertebrobasilar insufficiency →Diagnosis
- 21:1021:10, 2 December 2013 diff hist +912 Vertebrobasilar insufficiency →Diagnosis
- 20:5020:50, 2 December 2013 diff hist +215 Vertebrobasilar insufficiency →Pathophysiology
- 20:4420:44, 2 December 2013 diff hist +155 Vertebrobasilar insufficiency →Differentiating Vertebral Artery Disease from other Diseases
- 20:3820:38, 2 December 2013 diff hist +779 Vertebrobasilar insufficiency →Pathophysiology
- 20:0020:00, 2 December 2013 diff hist −2 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 19:5919:59, 2 December 2013 diff hist +1,010 Vertebrobasilar insufficiency →Epidemiology and Demographics
- 19:5519:55, 2 December 2013 diff hist +19 Vertebrobasilar insufficiency →Causes in Alphabetical Order
- 19:5519:55, 2 December 2013 diff hist +23 Vertebrobasilar insufficiency →Causes by Organ System
- 19:2719:27, 2 December 2013 diff hist +942 Vertebrobasilar insufficiency →Symptoms
- 18:0918:09, 2 December 2013 diff hist +604 Vertebrobasilar insufficiency →Common Causes
- 18:0618:06, 2 December 2013 diff hist −1 Vertebrobasilar insufficiency →Causes by Organ System
- 18:0418:04, 2 December 2013 diff hist +152 Vertebrobasilar insufficiency →Historical Perspective
- 17:2217:22, 2 December 2013 diff hist +277 Vertebrobasilar insufficiency →Causes in Alphabetical Order
- 17:2017:20, 2 December 2013 diff hist −14 Vertebrobasilar insufficiency →Causes by Organ System
- 15:3915:39, 2 December 2013 diff hist +77 Vertebrobasilar insufficiency →Causes by Organ System
27 November 2013
- 21:4921:49, 27 November 2013 diff hist +1,280 Vertebrobasilar insufficiency →Historical Perspective
- 18:4018:40, 27 November 2013 diff hist +532 Vertebrobasilar insufficiency →Historical Perspective
- 17:1417:14, 27 November 2013 diff hist +59 Vertebrobasilar insufficiency →Causes by Organ System
- 14:3214:32, 27 November 2013 diff hist +812 Vertebrobasilar insufficiency →Treatment
26 November 2013
- 21:4621:46, 26 November 2013 diff hist −1 Vertebrobasilar insufficiency →Symptoms
- 21:4521:45, 26 November 2013 diff hist +457 Vertebrobasilar insufficiency →Symptoms
- 21:4121:41, 26 November 2013 diff hist −419 Vertebrobasilar insufficiency →CT
- 21:4021:40, 26 November 2013 diff hist +419 Vertebrobasilar insufficiency →CT
- 21:0421:04, 26 November 2013 diff hist +23 Vertebrobasilar insufficiency →Causes by Organ System
- 20:5720:57, 26 November 2013 diff hist +21 Vertebrobasilar insufficiency →Causes by Organ System
- 20:4820:48, 26 November 2013 diff hist +35 Vertebrobasilar insufficiency →Causes by Organ System
- 20:3620:36, 26 November 2013 diff hist +44 Vertebrobasilar insufficiency →Causes by Organ System
- 20:2920:29, 26 November 2013 diff hist −2 Vertebrobasilar insufficiency →Causes by Organ System
- 20:2820:28, 26 November 2013 diff hist +79 Vertebrobasilar insufficiency →Causes by Organ System
- 19:5419:54, 26 November 2013 diff hist −128 Vertebrobasilar insufficiency →Life Threatening Causes
- 16:1216:12, 26 November 2013 diff hist −78 Lymphedema differential diagnosis No edit summary